3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Withdrawn
1
Unknown
1
Not yet recruiting
1
Completed
1
Sponsor Class
UNKNOWN
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Hepatocellular
22
Stomach Neoplasms
20
Carcinoma, Non-Small-Cell Lung
16
Colorectal Neoplasms
9
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Small Cell Lung Carcinoma
4
Neoplasms
4
Uterine Cervical Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Lymphoma, Extranodal NK-T-Cell
3
Liver Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Renal Cell
3
Carcinoma
3
Nonsquamous Non-Small Cell Lung Cancer
2
Nasopharyngeal Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Neuroendocrine
2
Advanced Biliary Tract Cancer
2
Unresectable Locally Advanced Pancreatic Cancer
1
Triple Negative Breast Neoplasms
1
Tislelizumab
1
Thoracic Neoplasms
1
Thoracic Malignancies
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Respiratory Tract Diseases
1
Recurrent/ Advanced Stage Endometrial Cancer Patients
1
Interventions
Fluorouracil
18
Oxaliplatin
17
Capecitabine
16
Leucovorin
13
Cisplatin
12
Gemcitabine
11
Drug Therapy
11
Irinotecan
10
Radiosurgery
9
Cetuximab
9
Bevacizumab
9
pembrolizumab
8
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
sintilimab
×
Clear all
NCT05136768
2021-11-29
LM-HNSCC
ChineseAMS
Phase 2
Unknown
50 enrolled